2021
DOI: 10.1186/s13568-021-01204-w
|View full text |Cite
|
Sign up to set email alerts
|

Numaswitch: an efficient high-titer expression platform to produce peptides and small proteins

Abstract: The production of peptides as active pharmaceutical ingredients (APIs) by recombinant technologies is of emerging interest. A reliable production platform, however, is still missing due the inherent characteristics of peptides such as proteolytic sensitivity, aggregation and cytotoxicity. We have developed a new technology named Numaswitch solving present limitations. Numaswitch was successfully employed for the production of diverse peptides and small proteins varying in length, physicochemical and functional… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 24 publications
0
8
0
Order By: Relevance
“…Another strategy (42) can produce higher peptide yields under fermentation (teriparatide: > 2 g/L) but requires cumbersome cell lysis, inclusion body recovery, and fusion protein cleavage to recover the desired peptide. We have not attempted to optimize export, but our studies using E. coli BL21(DE3) lacking proteases and lowering temperature indicate that peptide secretion abundance can be improved (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Another strategy (42) can produce higher peptide yields under fermentation (teriparatide: > 2 g/L) but requires cumbersome cell lysis, inclusion body recovery, and fusion protein cleavage to recover the desired peptide. We have not attempted to optimize export, but our studies using E. coli BL21(DE3) lacking proteases and lowering temperature indicate that peptide secretion abundance can be improved (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…[ 14 , 15 , 16 , 17 ] It should be noted that an engineered T1SS has recently been developed to allow efficient production of peptides and small proteins. [18] …”
Section: Introductionmentioning
confidence: 99%
“…Despite a long list of successfully secreted heterologous proteins, HlyA1 is still far away from being an universal secretion platform, due to a narrow range of possible substrates as well as low yields of secretion [14–17] . It should be noted that an engineered T1SS has recently been developed to allow efficient production of peptides and small proteins [18] …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Especially, pepteins of 30-300 amino acids length, covering such important families as long-chained peptides, disulfide-rich peptides, growth factors, peptide fusions and antibody fragments are of high interest and neither chemical synthesis nor traditional recombinant approaches are a reliable and cost-efficient production platform. To this end, we developed such a production platform called Numaswitch [1]. Here, bifunctional Switchtag proteins were developed combining two essential functions (Figure 1).…”
Section: Introductionmentioning
confidence: 99%